|
MechanismCCK receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1981 |
100 Clinical Results associated with CCKr Therapeutics, Inc.
0 Patents (Medical) associated with CCKr Therapeutics, Inc.
100 Deals associated with CCKr Therapeutics, Inc.
100 Translational Medicine associated with CCKr Therapeutics, Inc.